VYGR
Voyager Therapeutics, Inc.
NASDAQ · Healthcare · Biotechnology · US
$3.09
+1.64%Next report
Analyst consensus
- Next report date
- Nov 9, 2026
- EPS estimate
- -$0.41
- Revenue estimate
- $6.3M
Latest reported
- Last report date
- Aug 6, 2026
- EPS actual
- -$0.40
- EPS estimate
- -$0.48
- Revenue actual
- $3.2M
- Revenue estimate
- $4.5M
Track record
Trailing twelve quarters
- EPS beats (12Q)
- 8
- EPS misses (12Q)
- 4
- EPS in line (12Q)
- 0
- Avg surprise (4Q)
- +5.4%
- Revenue beats (12Q)
- 5
Reported history
| Report date | EPS estimate | EPS actual | Surprise | Revenue actual |
|---|---|---|---|---|
| Aug 6, 2026 | -$0.48 | -$0.40 | Beat 17.32% | $3.2M |
| May 7, 2026 | -$0.54 | -$0.47 | Beat 12.96% | $2.6M |
| Mar 9, 2026 | -$0.51 | -$0.46 | Beat 9.90% | $15.3M |
| Aug 6, 2025 | -$0.48 | -$0.57 | Miss -18.75% | $5.2M |
| Mar 11, 2025 | -$0.35 | -$0.59 | Miss -68.57% | $6.3M |
| Feb 28, 2024 | -$0.29 | $1.25 | Beat 531.03% | $90.1M |
| Aug 3, 2023 | -$0.59 | -$0.51 | Beat 13.56% | $4.9M |
| Mar 7, 2023 | -$0.57 | -$0.61 | Miss -7.02% | $41.1M |
| Aug 4, 2022 | -$0.56 | -$0.50 | Beat 10.71% | $712.0K |
| May 4, 2022 | -$0.14 | -$0.56 | Miss -300.00% | $658.0K |
| Mar 8, 2022 | -$0.32 | $0.15 | Beat 146.87% | $28.1M |
| Nov 2, 2021 | -$0.75 | -$0.67 | Beat 10.67% | $1.5M |
Reported results against consensus at the time of each report · Surprise is computed from the estimate on record · Data as of Nov 9, 2026